1353 related articles for article (PubMed ID: 16175177)
1. HSP90 and the chaperoning of cancer.
Whitesell L; Lindquist SL
Nat Rev Cancer; 2005 Oct; 5(10):761-72. PubMed ID: 16175177
[TBL] [Abstract][Full Text] [Related]
2. Constantly updated knowledge of Hsp90.
Terasawa K; Minami M; Minami Y
J Biochem; 2005 Apr; 137(4):443-7. PubMed ID: 15858167
[TBL] [Abstract][Full Text] [Related]
3. Hsp90: a chaperone for protein folding and gene regulation.
Zhao R; Houry WA
Biochem Cell Biol; 2005 Dec; 83(6):703-10. PubMed ID: 16333321
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 and Cdc37 -- a chaperone cancer conspiracy.
Pearl LH
Curr Opin Genet Dev; 2005 Feb; 15(1):55-61. PubMed ID: 15661534
[TBL] [Abstract][Full Text] [Related]
5. [Hsp90--a target for anticancer therapy].
Růcková E; Müller P; Vojtesek B
Klin Onkol; 2011; 24(5):329-37. PubMed ID: 22070013
[TBL] [Abstract][Full Text] [Related]
6. Hsp90: the vulnerable chaperone.
Chiosis G; Vilenchik M; Kim J; Solit D
Drug Discov Today; 2004 Oct; 9(20):881-8. PubMed ID: 15475321
[TBL] [Abstract][Full Text] [Related]
7. The Hsp90 molecular chaperone: an open and shut case for treatment.
Pearl LH; Prodromou C; Workman P
Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and regulation of the hsp90 machinery.
Li J; Buchner J
Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
[TBL] [Abstract][Full Text] [Related]
9. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.
Xu W; Neckers L
Clin Cancer Res; 2007 Mar; 13(6):1625-9. PubMed ID: 17363512
[No Abstract] [Full Text] [Related]
10. Altered Hsp90 function in cancer: a unique therapeutic opportunity.
Bagatell R; Whitesell L
Mol Cancer Ther; 2004 Aug; 3(8):1021-30. PubMed ID: 15299085
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 inhibitors as therapeutic agents.
Gomez-Monterrey I; Sala M; Musella S; Campiglia P
Recent Pat Anticancer Drug Discov; 2012 Sep; 7(3):313-36. PubMed ID: 22338602
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90: a unique chemotherapeutic target.
Cullinan SB; Whitesell L
Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
[TBL] [Abstract][Full Text] [Related]
13. The glucocorticoid responses are shaped by molecular chaperones.
Grad I; Picard D
Mol Cell Endocrinol; 2007 Sep; 275(1-2):2-12. PubMed ID: 17628337
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.
Kang BH; Plescia J; Dohi T; Rosa J; Doxsey SJ; Altieri DC
Cell; 2007 Oct; 131(2):257-70. PubMed ID: 17956728
[TBL] [Abstract][Full Text] [Related]
15. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance.
Sangster TA; Lindquist S; Queitsch C
Bioessays; 2004 Apr; 26(4):348-62. PubMed ID: 15057933
[TBL] [Abstract][Full Text] [Related]
16. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress.
Workman P; Burrows F; Neckers L; Rosen N
Ann N Y Acad Sci; 2007 Oct; 1113():202-16. PubMed ID: 17513464
[TBL] [Abstract][Full Text] [Related]
17. Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancer.
Workman P; Powers MV
Nat Chem Biol; 2007 Aug; 3(8):455-7. PubMed ID: 17637775
[No Abstract] [Full Text] [Related]
18. Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells.
Liu DH; Yuan HY; Cao CY; Gao ZP; Zhu BY; Huang HL; Liao DF
Acta Pharmacol Sin; 2007 Dec; 28(12):1907-13. PubMed ID: 18031603
[TBL] [Abstract][Full Text] [Related]
19. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.
McLaughlin SH; Sobott F; Yao ZP; Zhang W; Nielsen PR; Grossmann JG; Laue ED; Robinson CV; Jackson SE
J Mol Biol; 2006 Feb; 356(3):746-58. PubMed ID: 16403413
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
Moser C; Lang SA; Stoeltzing O
Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
